Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Morton Dl
Observed names:
D L Morton,
DL MORTON,
DL Morton
Institution:
Saint John's Health Center
Observed institutions:
University of California, Los Angeles,
Saint John's Health Center
OpenAlex ID:
A5111601765
Demonstration of antibodies against human malignant melanoma by immunofluorescence.
1968
·
D L Morton
, R A Malmgren
, et al.
·
PubMed
·
388
Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms.
1998
·
A J Bilchik
, A Giuliano
, et al.
·
PubMed
·
178
The determination of lymph shed by colloidal gold scanning in patients with malignant melanoma: a preliminary study.
1978
·
H J Fee
, D S Robinson
, et al.
·
PubMed
·
137
Immunologic and virus studies with human sarcomas.
1969
·
D L Morton
, R A Malmgren
, et al.
·
PubMed
·
101
Production of melanoma-associated antigen(s) by a defined malignant melanoma cell strain grown in chemically defined medium.
1976
·
D O Chee
, A W Boddie
, et al.
·
PubMed
·
73
Human leukocyte (alpha) interferon in metastatic malignant melanoma: the American Cancer Society phase II trial.
1984
·
S E Krown
, M W Burk
, et al.
·
PubMed
·
64
Lymphatic mapping and sentinel lymphadenectomy for melanoma: past, present, and future.
2001
·
D L Morton
·
PubMed
·
54
Immunosuppression by melanoma cells as a factor in the generation of metastatic disease.
1989
·
A J Cochran
, D R Wen
, et al.
·
PubMed
·
52
Intraoperative lymphatic mapping and sentinel lymphadenectomy: community standard care or clinical investigation?
1997
·
D L Morton
·
PubMed
·
47
Vaccine therapy for patients with melanoma.
1999
·
P I Haigh
, L A Difronzo
, et al.
·
PubMed
·
39
High-grade soft-tissue sarcomas of the extremity: UCLA experience with limb salvage.
1985
·
F R Eilber
, A E Guiliano
, et al.
·
PubMed
·
37
Cancer immunotherapy: an overview.
1974
·
D L Morton
·
PubMed
·
32
Horizons in tumor immunology.
1973
·
D L Morton
·
PubMed
·
28
CCNU nephrotoxicity following sustained remission in oat cell carcinoma.
1979
·
H K Silver
, D L Morton
·
PubMed
·
23
Demonstration of lymphocyte blastogenesis--inhibiting factors in sera of melanoma patients.
1977
·
D M Rangel
, S H Golub
, et al.
·
PubMed
·
21
Humoral immune response to intralymphatic immunotherapy for disseminated melanoma: correlation with clinical response.
1982
·
S S Ahn
, R F Irie
, et al.
·
PubMed
·
20
Immunotherapy of human melanomas and sarcomas.
1972
·
D L Morton
·
PubMed
·
19
Immunologic aspects of unknown primary melanoma.
1980
·
A E Giuliano
, H S Moseley
, et al.
·
PubMed
·
18
Immune response to postsurgical adjuvant active immunotherapy with Canvaxin polyvalent cancer vaccine: correlations with clinical course of patients with metastatic melanoma.
2004
·
D L Morton
·
PubMed
·
15
Hyperthermia: adjunctive modality for hepatic infusion chemotherapy.
1983
·
F K Storm
, D L Morton
·
PubMed
·
14
Adjuvant chemoimmunotherapy in advanced lesions of the head and neck
1976
·
FR Eilber
, DL Morton
·
American Journal of Roentgenology
·
13
Hybridoma monoclonal antibody: use in defining surface antigens on human lung carcinoma cells.
1981
·
M Kasai
, R E Saxton
, et al.
·
PubMed
·
12
Differential effects of granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor on tumor necrosis factor and interleukin-1 production in human monocytes.
1990
·
R Essner
, K Rhoades
, et al.
·
PubMed
·
9
Cancer immunology and the surgeon.
1970
·
D L Morton
·
PubMed
·
9
Treatment of metastatic disease.
1979
·
F K Storm
, D L Morton
·
PubMed
·
7
Show more works
View as search
Works count:
56
Citation count:
1,487
H-index:
18
I10-index:
22
Year
Topic
Type
